CASI / CASI Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

CASI Pharmaceuticals, Inc.
US ˙ NasdaqCM ˙ KYG1933S1012
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Deler fremragende 20,555,873 shares
Insideraktier5.054.144 shares
Insider ejerskab24,59 %
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

CASI Pharmaceuticals, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CASI / CASI Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2022-09-08 Huang James 33.300 4,2831 33.300 4,2831 142.627 5 4.6900 13.550 9,50
2022-09-07 Huang James 3.111 3,9965 3.111 3,9965 12.433
2022-09-06 Huang James 19.162 3,8932 19.162 3,8932 74.601
2022-09-02 Huang James 400 3,7413 400 3,7413 1.497
2022-09-01 Huang James 11.821 3,7229 11.821 3,7229 44.008
2022-08-31 Huang James 24.975 3,7450 24.975 3,7450 93.531
2022-08-26 Huang James 39.527 3,7488 39.527 3,7488 148.179
2022-08-24 Huang James 5.000 3,7502 5.000 3,7502 18.751
2022-08-23 Huang James 40.000 3,4998 40.000 3,4998 139.992

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CASI / CASI Pharmaceuticals, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CASI / CASI Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CASI / CASI Pharmaceuticals, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2022-09-08 2022-09-08 4 Huang James CASI Common Stock P - Purchase I 4,2831 33.300 143 371.517
2022-09-08 2022-09-07 4 Huang James CASI Common Stock P - Purchase I 3,9965 3.111 12 338.217
2022-09-08 2022-09-06 4 Huang James CASI Common Stock P - Purchase I 3,8932 19.162 75 335.106
2022-09-02 2022-09-02 4 Huang James CASI Common Stock P - Purchase I 3,7413 400 1 315.944
2022-09-02 2022-09-01 4 Huang James CASI Common Stock P - Purchase I 3,7229 11.821 44 315.544
2022-09-02 2022-08-31 4 Huang James CASI Common Stock P - Purchase I 3,7450 24.975 94 303.723
2022-08-26 2022-08-26 4 Huang James CASI Common Stock P - Purchase I 3,7488 39.527 148 278.748
2022-08-26 2022-08-24 4 Huang James CASI Common Stock P - Purchase I 3,7502 5.000 19 239.221
2022-08-23 2022-08-23 4 Huang James CASI Common Stock P - Purchase I 3,4998 40.000 140 234.221
2022-08-23 2022-08-22 4 Huang James CASI Common Stock P - Purchase I 3,4641 23.105 80 194.221
2022-08-23 2022-08-19 4 Huang James CASI Common Stock P - Purchase I 3,2694 171.116 559 171.116
2022-06-17 2022-06-15 4 He Wei-Wu CASI Common Stock P - Purchase D 3,1800 50.000 159 644.553
2022-06-17 2022-06-14 4 He Wei-Wu CASI Common Stock P - Purchase D 3,0600 2.096 6 594.553
2022-06-17 2022-06-13 4 He Wei-Wu CASI Common Stock P - Purchase D 2,9700 36.058 107 592.457
2022-05-26 2022-05-25 4 Zhou Quan CASI Stock Option (Right to Buy) A - Award D 0,47 380.645 380.645
2022-05-26 2022-05-25 4 Salisbury Franklin Cary jr CASI Stock Option (Right to Buy) A - Award D 0,47 388.387 388.387
2022-05-26 2022-05-25 4 Huang James CASI Stock Option (Right to Buy) A - Award D 0,47 397.419 397.419
2022-05-26 2022-05-25 4 Wu Yue Alexander CASI Stock Option (Right to Buy) A - Award D 0,47 388.387 388.387
2022-05-26 2022-05-25 4 SHROTRIYA RAJESH C MD CASI Stock Option (Right to Buy) A - Award D 0,47 345.806 345.806
2021-12-06 2021-12-02 4 Zukiwski Alexander A CASI Employee Stock Option (Right to Buy) A - Award D 0,87 -500.000 500.000
2021-11-19 2021-11-18 4 He Wei-Wu CASI Common Stock P - Purchase D 0,9800 200.000 196 5.558.472
2021-11-19 2021-11-17 4 He Wei-Wu CASI Common Stock P - Purchase D 0,9900 200.000 198 5.362.569
2021-08-20 2021-08-19 4 He Wei-Wu CASI Common Stock P - Purchase D 1,2600 180.000 227 5.163.994
2021-08-20 2021-08-18 4 He Wei-Wu CASI Common Stock P - Purchase D 1,2900 300.000 387 4.983.994
2021-07-26 2021-07-24 4 Zhang Larry CASI Employee Stock Option (Right to Buy) A - Award D 1,28 -800.000 800.000
2021-06-16 2021-06-15 4 SHROTRIYA RAJESH C MD CASI Stock Option (Right to Buy) A - Award D 1,65 98 98.349
2021-06-16 2021-06-15 4 Zhou Quan CASI Stock Option (Right to Buy) A - Award D 1,65 108.257 108.257
2021-06-16 2021-06-15 4 Wu Yue Alexander CASI Stock Option (Right to Buy) A - Award D 1,65 110.459 110.459
2021-06-16 2021-06-15 4 He Wei-Wu CASI Stock Options (Right to Buy) A - Award D 1,73 4.000.000 4.000.000
2021-06-16 2021-06-15 4 Huang James CASI Stock Option (Right to Buy) A - Award D 1,65 113.028 113.028
2021-06-16 2021-06-15 4 Salisbury Franklin Cary jr CASI Stock Option (Right to Buy) A - Award D 1,65 110.459 110.459
2021-03-30 2021-03-26 4 He Wei-Wu CASI Common Stock P - Purchase I 2,0500 3.000.000 6.150 3.000.000
2020-12-23 2020-12-22 4 He Wei-Wu CASI Common Stock G - Gift D -380.000 4.683.994
2020-12-18 3 Xu Weihao Held by spouse CASI Common Stock I 4.000
2020-12-18 2020-12-17 4 Xu Weihao Held by spouse CASI Common Stock P - Purchase I 2,6300 2.279 6 10.000
2020-12-18 2020-12-17 4 Xu Weihao Held by spouse CASI Common Stock P - Purchase I 2,6400 1.721 5 7.721
2020-12-18 2020-12-16 4 Xu Weihao CASI Employee Stock Option (Right to Buy) A - Award D 2,61 800.000 800.000
2020-12-18 2020-12-16 4 Xu Weihao Held by spouse CASI Common Stock P - Purchase I 2,4400 2.000 5 6.000
2020-11-24 2020-11-23 4 He Wei-Wu CASI Common Stock P - Purchase D 2,1800 100.000 218 5.063.994
2020-11-24 2020-11-20 4 He Wei-Wu CASI Common Stock P - Purchase D 2,1200 127.471 270 4.963.994
2020-07-24 2020-07-22 4 Zhang Larry CASI Common Stock P - Purchase D 1,9000 20.153 38 20.153
2020-07-24 2020-07-22 4 He Wei-Wu CASI Common Stock P - Purchase I 1,9000 1.200.000 2.280 7.532.347
2020-07-24 2020-07-22 4 He Wei-Wu CASI Common Stock P - Purchase D 1,9000 2.952.426 5.610 4.836.523
2020-06-18 2020-06-16 4 Huang James CASI Stock Option (Right to Buy) A - Award D 2,63 70.400 70.400
2020-06-18 2020-06-16 4 Zhou Quan CASI Stock Option (Right to Buy) A - Award D 2,63 67.429 67.429
2020-06-18 2020-06-16 4 SHROTRIYA RAJESH C MD CASI Stock Option (Right to Buy) A - Award D 2,63 61.257 61.257
2020-06-18 2020-06-16 4 Salisbury Franklin Cary jr CASI Stock Option (Right to Buy) A - Award D 2,63 68.800 68.800
2020-06-18 2020-06-16 4 Wu Yue Alexander CASI Stock Option (Right to Buy) A - Award D 2,63 68.800 68.800
2020-05-21 2020-05-20 4 He Wei-Wu CASI Common Stock P - Purchase D 2,3700 56.464 134 1.884.097
2020-05-21 2020-05-19 4 He Wei-Wu CASI Common Stock P - Purchase D 2,0300 29.801 60 1.827.663
2020-05-19 2020-05-18 4 He Wei-Wu CASI Common Stock P - Purchase D 2,0200 338.932 685 1.797.832
2020-05-19 2020-05-15 4 He Wei-Wu CASI Common Stock P - Purchase D 1,8200 100.000 182 1.458.900
2020-03-30 2020-03-27 4 He Wei-Wu CASI Common Stock P - Purchase D 2,0800 6.880 14 1.358.900
2020-03-27 2020-03-26 4 He Wei-Wu CASI Common Stock P - Purchase D 2,0900 328.095 686 1.352.020
2020-03-27 2020-03-25 4 He Wei-Wu CASI Common Stock P - Purchase D 1,9400 196.398 381 1.023.925
2020-03-19 2020-03-19 4 He Wei-Wu CASI Common Stock P - Purchase I 1,5700 234.488 368 6.332.347
2020-03-19 2020-03-18 4 He Wei-Wu CASI Common Stock P - Purchase I 1,5200 501.322 762 6.097.859
2020-03-19 2020-03-17 4 He Wei-Wu CASI Common Stock P - Purchase I 1,5000 264.192 396 5.596.537
2020-01-06 2019-12-30 4 Wealth Strategy Holding Ltd CASI Warrant X - Other D 1,69 0,1250 -493.827 -62 0
2020-01-06 2019-12-30 4 Wealth Strategy Holding Ltd CASI Common Stock X - Other D 1,6900 493.827 835 9.087.888
2019-12-18 2019-12-16 4 He Wei-Wu CASI Warrant X - Other I 1,69 -374.321 0
2019-12-18 2019-12-16 4 He Wei-Wu CASI Common Stock X - Other I 1,6900 374.321 633 5.332.345
2019-12-17 2019-12-15 4 Zukiwski Alexander A CASI Employee Stock Option (Right to Buy) A - Award D 3,16 -200.000 200.000
2019-09-24 2019-09-20 4 Zhang Larry CASI Employee Stock Option (Right to Buy) A - Award D 3,35 -200.000 200.000
2019-08-20 2019-08-16 4 He Wei-Wu CASI Common Stock P - Purchase D 3,2000 20.000 64 827.527
2019-08-15 2019-08-14 4 He Wei-Wu CASI Common Stock P - Purchase D 3,1700 160.000 507 807.527
2019-06-21 2019-06-20 4 Zhou Quan CASI Stock Option (Right to Buy) A - Award D 3,13 56.731 56.731
2019-06-21 2019-06-20 4 He Wei-Wu CASI Stock Option (Right to Buy) A - Award D 2,85 4.000.000 4.000.000
2019-06-21 2019-06-20 4 SHROTRIYA RAJESH C MD CASI Stock Option (Right to Buy) A - Award D 3,13 51.538 51.538
2019-06-21 2019-06-20 4 Ren Ken Keyong CASI Stock Option (Right to Buy) A - Award D 3,13 51.538 51.538
2019-06-21 2019-06-20 4 Huang James CASI Stock Option (Right to Buy) A - Award D 3,13 59.231 59.231
2019-06-21 2019-06-20 4 Salisbury Franklin Cary jr CASI Stock Option (Right to Buy) A - Award D 3,13 57.885 57.885
2019-06-21 2019-06-20 4 Wu Yue Alexander CASI Stock Option (Right to Buy) A - Award D 3,13 57.885 57.885
2019-04-04 2019-04-02 4 SPECTRUM PHARMACEUTICALS INC CASI Common Stock J - Other D 3,3828 -1.500.000 -5.074 5.397.413
2019-02-06 3 Li Dapeng CASI Common Stock D 15.513.602
2019-02-06 3 Li Dapeng CASI Common Stock D 15.513.602
2019-02-06 3 Li Dapeng CASI Common Stock D 15.513.602
2019-02-06 3 Li Dapeng By Zhejiang Kanglaite Group Co., Ltd. CASI Common Stock I 11.312.325
2019-02-06 3 Li Dapeng CASI Common Stock D 10.278.975
2019-02-06 3 Li Dapeng By Zhejiang Kanglaite Group Co., Ltd. CASI Common Stock I 11.312.325
2019-02-06 3 Li Dapeng CASI Common Stock D 10.278.975
2019-02-06 3 Li Dapeng By Zhejiang Kanglaite Group Co., Ltd. CASI Common Stock I 11.312.325
2019-02-06 3 Li Dapeng CASI Common Stock D 10.278.975
2019-01-31 2019-01-29 4 Ren Ken Keyong CASI Stock Options (Right to Buy) A - Award D 0,88 75.000 75.000
2019-01-31 2019-01-29 4 Hu Cynthia W. CASI Stock Options (Right to Buy) A - Award D 0,88 75.000 75.000
2019-01-15 2019-01-14 4 Hu Cynthia W. CASI Employee Stock Option (Right to Buy) M - Exercise D 1,76 -15.000 0
2019-01-15 2019-01-14 4 Hu Cynthia W. CASI Common Stock F - Taxes D 3,7900 -3.100 -12 29.685
2019-01-15 2019-01-14 4 Hu Cynthia W. CASI Common Stock M - Exercise D 1,7600 15.000 26 32.785
2018-12-21 2018-12-19 4 He Wei-Wu CASI Common Stock G - Gift D -200.000 647.527
2018-12-06 2018-12-03 4 Ren Ken Keyong CASI Stock Options (Right to Buy) A - Award D 0,99 720.000 720.000
2018-11-14 2018-11-13 4 SPARKLE BYTE LTD CASI Warrant X - Other D 1,69 0,1250 -750.771 -94 0
2018-11-14 2018-11-13 4 SPARKLE BYTE LTD CASI Warrant X - Other D 1,69 0,1250 -948.982 -119 0
2018-11-14 2018-11-13 4 SPARKLE BYTE LTD CASI Common Stock X - Other D 1,6900 1.699.753 2.873 10.198.518
2018-10-31 3 Wealth Strategy Holding Ltd CASI Common Stock D 17.188.122
2018-10-31 3 Wealth Strategy Holding Ltd CASI Common Stock D 17.188.122
2018-10-31 3 Wealth Strategy Holding Ltd CASI Common Stock D 17.188.122
2018-10-02 2018-09-28 4 Chi George CASI Stock Options (Right to Buy) A - Award D 4,67 400.000 400.000
2018-07-13 2018-07-12 4 CAPITELLI SARA B CASI Employee Stock Option (Right to Buy) M - Exercise D 1,98 -35.000 0
2018-07-13 2018-07-12 4 CAPITELLI SARA B CASI Common Stock D - Sale to Issuer D 7,4893 -26.600 -199 0
2018-07-13 2018-07-12 4 CAPITELLI SARA B CASI Common Stock F - Taxes D 7,4893 -8.400 -63 26.600
2018-07-13 2018-07-12 4 CAPITELLI SARA B CASI Common Stock M - Exercise D 1,9850 35.000 69 35.000
2018-07-03 2018-06-29 4 SHROTRIYA RAJESH C MD CASI Stock Options (Right to Buy) A - Award D 8,23 35.000 35.000
2018-07-03 2018-06-29 4 Wu Alex CASI Stock Options (Right to Buy) A - Award D 8,23 35.000 35.000
2018-07-03 2018-06-29 4 Salisbury Franklin Cary jr CASI Stock Options (Right to Buy) A - Award D 8,23 35.000 35.000
2018-07-03 2018-06-29 4 Zhou Quan CASI Stock Options (Right to Buy) A - Award D 8,23 50.000 50.000
2018-07-03 2018-06-29 4 Huang James CASI Stock Options (Right to Buy) A - Award D 8,23 50.000 50.000
2018-06-12 2018-06-11 4 He Wei-Wu CASI Stock Options (Right to Buy) A - Award D 3,22 1.000.000 1.000.000
2018-04-13 2018-04-12 4 CAPITELLI SARA B CASI Employee Stock Option (Right to Buy) M - Exercise D 0,88 -26.978 0
2018-04-13 2018-04-12 4 CAPITELLI SARA B CASI Common Stock D - Sale to Issuer D 6,6200 -18.778 -124 0
2018-04-13 2018-04-12 4 CAPITELLI SARA B CASI Common Stock F - Taxes D 6,6200 -8.200 -54 18.778
2018-04-13 2018-04-12 4 CAPITELLI SARA B CASI Common Stock M - Exercise D 0,8800 26.978 24 26.978
2018-04-06 2018-04-04 4 Huang James CASI Common Stock J - Other D 191 191
2018-04-06 2018-04-04 4 Huang James CASI Common Stock J - Other I -416.666 0
2018-03-23 2018-03-21 4 IDG-Accel China Growth Fund III L.P. CASI Warrant P - Purchase D 3,69 0,1250 1.152.839 144 81.728
2018-03-23 2018-03-21 4 IDG-Accel China Growth Fund III L.P. See Explanation of Responses CASI Warrant P - Purchase I 3,69 0,1250 1.152.839 144 81.728
2018-03-23 2018-03-21 4 IDG-Accel China Growth Fund III L.P. See Explanation of Responses CASI Common Stock P - Purchase I 3,1900 204.320 652 646.995
2018-03-23 2018-03-21 4 IDG-Accel China Growth Fund III L.P. CASI Common Stock P - Purchase D 3,1900 2.882.098 9.194 9.126.375
2018-03-21 2018-03-19 4 He Wei-Wu CASI Warrants (Right to Buy) A - Award I 3,69 1.234.567 1.234.567
2018-03-21 2018-03-19 4 He Wei-Wu CASI Common Stock P - Purchase I 3,2400 3.086.419 10.000 4.958.024
2017-12-22 2017-12-22 4 SPECTRUM PHARMACEUTICALS INC CASI Common Stock P - Purchase I 0,0100 611.740 6 4.650.262
2017-12-22 2017-12-22 4 SPECTRUM PHARMACEUTICALS INC CASI Common Stock P - Purchase D 0,0100 907.356 9 6.897.413
2017-10-11 2017-10-10 4 He Wei-Wu CASI Common Stock P - Purchase D 1,9500 100.000 195 847.527
2017-10-10 2017-10-06 4 He Wei-Wu CASI Common Stock P - Purchase D 1,8600 100.000 186 747.527
2017-10-10 2017-10-05 4 He Wei-Wu CASI Common Stock P - Purchase D 1,8000 100.000 180 647.527
2017-10-06 2017-07-10 4 Hu Cynthia W. CASI Stock Options (Right to Buy) A - Award D 1,01 50.000 50.000
2017-10-03 2017-09-29 4 Hu Cynthia W. CASI Stock Options (Right to Buy) A - Award D 1,98 50.000 50.000
2017-10-03 2017-09-29 4 CAPITELLI SARA B CASI Stock Options (Right to Buy) A - Award D 1,98 20.000 20.000
2017-09-20 2017-09-19 4 He Wei-Wu CASI Common Stock P - Purchase D 1,7800 34.002 61 547.527
2017-09-20 2017-09-18 4 He Wei-Wu CASI Common Stock P - Purchase D 1,7500 173.500 304 513.525
2017-09-18 2017-09-15 4 He Wei-Wu CASI Common Stock P - Purchase D 1,4900 127.702 190 340.025
2017-09-18 2017-09-14 4 He Wei-Wu CASI Common Stock P - Purchase D 1,2200 187.625 229 212.323
2017-06-09 2017-06-08 4 Hu Cynthia W. CASI Stock Options (Right to Buy) A - Award D 1,01 100.000 100.000
2017-06-09 2017-06-08 4 Zhou Quan CASI Stock Options (Right to Buy) A - Award D 1,01 50.000 50.000
2017-06-09 2017-06-08 4 He Wei-Wu CASI Stock Options (Right to Buy) A - Award D 1,01 100.000 100.000
2017-06-09 2017-06-08 4 Huang James CASI Stock Options (Right to Buy) A - Award D 1,01 50.000 50.000
2017-06-09 2017-06-08 4 Salisbury Franklin Cary jr CASI Stock Options (Right to Buy) A - Award D 1,01 35.000 35.000
2017-06-09 2017-06-08 4 SHROTRIYA RAJESH C MD CASI Stock Options (Right to Buy) A - Award D 1,01 35.000 35.000
2017-06-09 2017-06-08 4 Wu Alex CASI Stock Options (Right to Buy) A - Award D 1,01 35.000 35.000
2017-06-09 2017-06-08 4 CAPITELLI SARA B CASI Stock Options (Right to Buy) A - Award D 1,01 50.000 50.000
2017-04-05 2017-04-03 4 Zukiwski Alexander A CASI Stock Options (Right to Buy) A - Award D 1,34 300.000 300.000
2016-11-01 2016-10-28 4 SPECTRUM PHARMACEUTICALS INC CASI Common Stock P - Purchase I 0,0100 198.765 2 4.038.522
2016-11-01 2016-10-28 4 SPECTRUM PHARMACEUTICALS INC CASI Common Stock P - Purchase I 0,0100 521.692 5 3.839.757
2016-11-01 2016-10-28 4 SPECTRUM PHARMACEUTICALS INC CASI Common Stock P - Purchase D 0,0100 294.815 3 5.990.057
2016-11-01 2016-10-28 4 SPECTRUM PHARMACEUTICALS INC CASI Common Stock P - Purchase D 0,0100 773.790 8 5.695.242
2016-10-25 2016-10-24 4 He Wei-Wu CASI Stock Options (Right to Buy) A - Award D 1,40 202.247 202.247
2016-10-05 2016-10-03 4 Ren Ken Keyong CASI Stock Options (Right to Buy) A - Award D 1,11 308.571 308.571
2016-10-05 2016-10-03 4 He Wei-Wu See footnotes CASI Warrants A - Award I 1,69 0,0250 374.321 9 374.321
2016-10-05 2016-10-03 4 He Wei-Wu CASI Stock Options (Right to Buy) A - Award D 1,11 366.343 366.343
2016-10-05 2016-10-03 4 He Wei-Wu See footnotes CASI Common Stock P - Purchase I 1,1900 1.871.605 2.227 1.871.605
2016-08-16 2016-07-20 4 SPECTRUM PHARMACEUTICALS INC CASI Common Stock P - Purchase I 0,0100 66.255 1 3.318.065
2016-08-16 2016-07-20 4 SPECTRUM PHARMACEUTICALS INC CASI Common Stock P - Purchase D 0,0100 98.271 1 4.921.452
2016-08-16 2016-07-14 4 SPECTRUM PHARMACEUTICALS INC CASI Common Stock P - Purchase I 0,0100 394.942 4 3.251.810
2016-08-16 2016-07-14 4 SPECTRUM PHARMACEUTICALS INC CASI Common Stock P - Purchase D 0,0100 585.790 6 4.823.181
2016-07-06 2016-07-05 4 He Wei-Wu CASI Stock Options (Right to Buy) A - Award D 1,10 84.507 84.507
2016-06-29 2016-06-24 4 SPARKLE BYTE LTD CASI Warrant P - Purchase D 1,69 0,0250 750.771 19 1.699.753
2016-06-29 2016-06-24 4 SPARKLE BYTE LTD CASI Common Stock P - Purchase D 1,1900 3.753.855 4.467 8.498.765
2016-06-27 2016-06-24 4 He Wei-Wu CASI Stock Options (Right to Buy) A - Award D 1,15 369.805 369.805
2016-06-27 2016-06-24 4 Hu Cynthia W. CASI Stock Options (Right to Buy) A - Award D 1,15 27.027 27.027
2016-06-27 2016-06-24 4 Ren Ken Keyong CASI Stock Options(Right to Buy) A - Award D 1,15 86.486 86.486
2016-06-03 2016-06-02 4 He Wei-Wu CASI Stock Options (Right to Buy) A - Award D 0,86 712.112 712.112
2016-06-03 2016-06-02 4 Hu Cynthia W. CASI Stock Options (Right to Buy) A - Award D 0,86 87.719 87.719
2016-06-03 2016-06-02 4 Ren Ken Keyong CASI Stock Options (Right to Buy) A - Award D 0,86 280.701 280.701
2016-06-03 2016-06-02 4 Zhou Quan CASI Stock Options (Right to Buy) A - Award D 1,26 50.000 50.000
2016-03-11 2016-02-22 4 SPECTRUM PHARMACEUTICALS INC CASI Common Stock P - Purchase I 0,0100 680.113 7 2.856.868
2016-03-11 2016-02-22 4 SPECTRUM PHARMACEUTICALS INC CASI Common Stock P - Purchase D 0,0100 1.008.764 10 4.237.391
2016-03-04 2016-03-02 4 Hu Cynthia W. CASI Stock Options (Right to Buy) A - Award D 0,88 95.000 95.000
2016-03-04 2016-03-02 4 Mak Tak W. CASI Stock Options (Right to Buy) A - Award D 0,88 35.000 35.000
2016-03-04 2016-03-02 4 Huang James CASI Options (Right to Buy) A - Award D 0,88 75.000 75.000
2016-03-04 2016-03-02 4 CAPITELLI SARA B CASI Stock Options (Right to Buy) A - Award D 0,88 35.000 35.000
2016-03-04 2016-03-02 4 Ren Ken Keyong CASI Stock Options (Right to Buy) A - Award D 0,88 125.000 125.000
2016-03-04 2016-03-02 4 Salisbury Franklin Cary jr CASI Stock Options (Right to Buy) A - Award D 0,88 35.000 35.000
2016-03-04 2016-03-02 4 SHROTRIYA RAJESH C MD CASI Stock Options (Right to Buy) A - Award D 0,88 35.000 35.000
2016-03-04 2016-03-02 4 He Wei-Wu CASI Stock Options (Right to Buy) A - Award D 0,88 100.000 100.000
2016-03-04 2016-03-02 4 Wu Alex CASI Options (Right to Buy) A - Award D 0,88 35.000 35.000
2016-01-27 3 Zhou Quan See Explanation of Responses CASI Common Stock I 4.702.708
2016-01-27 3 Zhou Quan CASI Common Stock D 8.529.449
2016-01-27 3 Zhou Quan See Explanation of Responses CASI Common Stock I 4.702.708
2016-01-27 3 Zhou Quan CASI Common Stock D 8.529.449
2016-01-27 3 Zhou Quan See Explanation of Responses CASI Common Stock I 4.702.708
2016-01-27 3 Zhou Quan See Explanation of Responses CASI Common Stock I 4.702.708
2016-01-27 3 Zhou Quan See Explanation of Responses CASI Common Stock I 4.702.708
2016-01-27 3 Zhou Quan CASI Common Stock D 8.529.449
2016-01-27 3 Zhou Quan See Explanation of Responses CASI Common Stock I 4.702.708
2016-01-27 3 Zhou Quan CASI Common Stock D 8.529.449
2016-01-27 3 Zhou Quan CASI Common Stock D 8.529.449
2016-01-27 3 Zhou Quan CASI Common Stock D 8.529.449
2016-01-27 3 Zhou Quan See Explanation of Responses CASI Common Stock I 4.702.708
2016-01-27 3 Zhou Quan CASI Common Stock D 8.529.449
2016-01-27 2013-03-07 4 IDG-Accel China Growth Fund III L.P. See Explanation of Responses CASI Warrant P - Purchase I 2,91 34.479 92.044
2016-01-27 2013-03-07 4 IDG-Accel China Growth Fund III L.P. CASI Warrant P - Purchase D 2,91 486.354 1.298.354
2016-01-27 2013-03-07 4 IDG-Accel China Growth Fund III L.P. See Explanation of Responses CASI Common Stock P - Purchase I 2,4000 68.958 165 360.947
2016-01-27 2013-03-07 4 IDG-Accel China Growth Fund III L.P. CASI Common Stock P - Purchase D 2,4000 972.708 2.334 5.091.438
2016-01-25 3 Shong Hugo CASI Common Stock D 9.489.820
2016-01-25 3 Shong Hugo CASI Common Stock D 9.489.820
2016-01-25 3 Shong Hugo CASI Common Stock D 9.489.820
2016-01-25 3 Shong Hugo CASI Common Stock D 9.489.820
2016-01-25 3 Shong Hugo CASI Common Stock D 9.489.820
2016-01-25 3 Shong Hugo CASI Common Stock D 9.489.820
2016-01-25 3 Shong Hugo CASI Common Stock D 9.489.820
2016-01-25 3 Shong Hugo CASI Common Stock D 9.489.820
2016-01-25 3 Shong Hugo CASI Common Stock D 9.489.820
2016-01-25 3 Shong Hugo CASI Common Stock D 9.489.820
2016-01-21 2016-01-19 4 Ren Ken Keyong CASI Common Stock P - Purchase D 0,7100 300 0 15.000
2016-01-21 2016-01-19 4 Ren Ken Keyong CASI Common Stock P - Purchase D 0,7200 6.063 4 14.700
2016-01-21 2016-01-19 4 Ren Ken Keyong CASI Common Stock P - Purchase D 0,7400 1.100 1 8.637
2016-01-21 2016-01-19 4 Ren Ken Keyong CASI Common Stock P - Purchase D 0,7300 7.537 6 7.537
2016-01-21 2016-01-19 4 Ren Ken CASI Common Stock P - Purchase D 0,7100 300 0 15.000
2016-01-21 2016-01-19 4 Ren Ken CASI Common Stock P - Purchase D 0,7200 6.063 4 14.700
2016-01-21 2016-01-19 4 Ren Ken CASI Common Stock P - Purchase D 0,7400 1.100 1 8.637
2016-01-21 2016-01-19 4 Ren Ken CASI Common Stock P - Purchase D 0,7300 7.537 6 7.537
2016-01-21 2016-01-19 4 Hu Cynthia W. CASI Common Stock P - Purchase D 0,7197 11.837 9 17.785
2016-01-21 2016-01-19 4 Hu Cynthia W. CASI Common Stock P - Purchase D 0,7190 4.163 3 5.948
2016-01-21 2016-01-19 4 Hu Cynthia W. CASI Common Stock P - Purchase D 0,7497 400 0 1.785
2016-01-21 2016-01-19 4 Hu Cynthia W. CASI Common Stock P - Purchase D 0,7478 400 0 1.385
2015-04-08 2015-04-06 4 Hu Cynthia W. CASI Stock Options (Right to Buy) A - Award D 1,41 175.000 175.000
2015-04-08 2015-04-06 4 Mak Tak W. CASI Stock Options(Right to Buy) A - Award D 1,41 35.000 35.000
2015-04-08 2015-04-06 4 Huang James CASI Options(Right to Buy) A - Award D 1,41 75.000 75.000
2015-04-08 2015-04-06 4 Wu Alex CASI Options(Right to Buy) A - Award D 1,41 35.000 35.000
2015-04-08 2015-04-06 4 CAPITELLI SARA B CASI Stock Options (Right to Buy) A - Award D 1,41 65.000 65.000
2015-04-08 2015-04-06 4 He Wei-Wu CASI Stock Options (Right to Buy) A - Award D 1,41 100.000 100.000
2015-04-08 2015-04-06 4 Ren Ken Keyong CASI Stock Options(Right to Buy) A - Award D 1,41 225.000 225.000
2015-04-08 2015-04-06 4 Salisbury Franklin Cary jr CASI Stock Options(Right to Buy) A - Award D 1,41 35.000 35.000
2015-04-08 2015-04-06 4 SHROTRIYA RAJESH C MD CASI Stock Options(Right to Buy) A - Award D 1,41 35.000 35.000
2014-11-14 2012-08-15 4 CAPITELLI SARA B CASI Stock Options (Right to Buy) A - Award D 1,98 20.000 20.000
2014-11-14 2014-04-03 4 Hu Cynthia W. CASI Stock Options (Right to Buy) A - Award D 1,84 100.000 100.000
2014-11-14 2012-08-15 4 Hu Cynthia W. CASI Stock Options (Right to Buy) A - Award D 1,98 50.000 50.000
2014-11-14 2014-04-03 4 Huang James CASI Options(Right to Buy) A - Award D 1,84 100.000 100.000
2014-11-14 2014-04-03 4 He Wei-Wu CASI Stock Options (Right to Buy) A - Award D 1,84 100.000 100.000
2014-11-14 2014-04-03 4 Ren Ken Keyong CASI Stock Options(Right to Buy) A - Award D 1,84 100.000 100.000
2014-09-25 3 Spectrum Pharmaceuticals Cayman, L.P. CASI Common Stock I 7.582.137
2014-09-25 3 Spectrum Pharmaceuticals Cayman, L.P. CASI Common Stock I 7.582.137
2014-09-25 3 Spectrum Pharmaceuticals Cayman, L.P. CASI Common Stock D 8.634.009
2014-09-25 3 Spectrum Pharmaceuticals Cayman, L.P. CASI Common Stock I 7.582.137
2014-09-25 3 Spectrum Pharmaceuticals Cayman, L.P. CASI Common Stock D 8.634.009
2014-09-25 3 Spectrum Pharmaceuticals Cayman, L.P. CASI Common Stock D 8.634.009
2014-09-23 2014-09-22 4 SHROTRIYA RAJESH C MD CASI Stock Options (Right to Buy) A - Award D 1,80 50.000 50.000
2014-06-03 2014-06-02 4 Salisbury Franklin Cary jr ENMD Stock Options (Right to Buy) A - Award D 1,74 50.000 50.000
2014-04-04 2014-04-03 4 Hu Cynthia W. ENMD Stock Options (Right to Buy) A - Award D 1,84 130.000 130.000
2014-04-04 2014-04-03 4 He Wei-Wu ENMD Stock Options (Right to Buy) A - Award D 1,84 100.000 100.000
2014-04-04 2014-04-03 4 Ren Ken Keyong ENMD Stock Options(Right to Buy) A - Award D 1,84 150.000 150.000
2014-04-04 2014-04-03 4 CAPITELLI SARA B ENMD Stock Options (Right to Buy) A - Award D 1,84 55.000 55.000
2014-04-04 2014-04-03 4 Wu Alex ENMD Options (Right to Buy) A - Award D 1,84 25.000 25.000
2014-04-04 2014-04-03 4 Mak Tak W. ENMD Stock Options (Right to Buy) A - Award D 1,84 25.000 25.000
2014-04-04 2014-04-03 4 Huang James ENMD Options (Right to Buy) A - Award D 1,84 75.000 75.000
2013-05-31 2013-05-30 4 CAPITELLI SARA B ENMD Stock Options (Right to Buy) A - Award D 1,79 125.000 125.000
2013-05-31 2013-05-30 4 HUNTER CEVERA JENNIE ENMD Stock Options (Right to Buy) A - Award D 1,79 37.500 37.500
2013-05-31 2013-05-30 4 Hu Cynthia W. ENMD Stock Options (Right to Buy) A - Award D 1,79 350.000 350.000
2013-05-31 2013-05-30 4 He Wei-Wu ENMD Stock Options (Right to Buy) A - Award D 1,79 100.000 100.000
2013-05-31 2013-05-30 4 He Wei-Wu ENMD Stock Options (Right to Buy) A - Award D 1,79 125.000 125.000
2013-05-31 2013-05-30 4 Huang James ENMD Stock Options (Right to Buy) A - Award D 1,79 50.000 50.000
2013-05-31 2013-05-30 4 Wu Alex ENMD Stock Options (Right to Buy) A - Award D 1,79 50.000 50.000
2013-05-31 2013-05-30 4 BUSH DWIGHT L ENMD Stock Options (Right to Buy) A - Award D 1,79 37.500 37.500
2013-05-31 2013-05-30 4 Mak Tak W. ENMD Stock Options (Right to Buy) A - Award D 1,79 37.500 37.500
2013-05-31 2013-05-30 4 Ren Ken Keyong ENMD Stock Options (Right to Buy) A - Award D 1,79 1.000.000 1.000.000
2013-04-12 3 Huang James See footnotes ENMD Common Stock I 416.666
2012-08-17 2012-08-15 4 Hu Cynthia W. ENMD Stock Options (Right to Buy) A - Award D 1,98 75.000 75.000
2012-08-17 2012-08-15 4 CAPITELLI SARA B ENMD Stock Options (Right to Buy) A - Award D 1,98 35.000 35.000
2012-05-03 2012-05-01 4 He Wei-Wu ENMD Common Stock P - Purchase I 441.072 441.072
2012-05-03 2012-01-20 4 He Wei-Wu ENMD Warrants (Right to Buy) A - Award I 1,40 86.957 86.957
2012-05-03 2012-05-01 4 Hu Cynthia W. ENMD Common Stock P - Purchase I 74.982 74.982
2012-05-03 2012-01-20 4 Hu Cynthia W. ENMD Warrant (Right to Buy) A - Award I 1,40 14.783 14.783
2012-05-03 2012-05-01 4 Mak Tak W. ENMD Common Stock P - Purchase D 352.857 365.376
2012-05-03 2012-01-20 4 Mak Tak W. ENMD Warrants (Right to Buy) A - Award D 1,40 69.565 69.565
2012-04-03 2012-04-02 4 Ren Ken Keyong ENMD Stock Options (Right to Buy) A - Award D 2,16 150.000 150.000
2012-03-14 2012-03-12 4 BUSH DWIGHT L ENMD Stock Options (Right to Buy) A - Award D 2,30 100.000 100.000
2012-03-14 2012-03-12 4 Mak Tak W. ENMD Stock Options (Right to Buy) A - Award D 2,30 125.000 125.000
2012-03-14 2012-03-12 4 HUNTER CEVERA JENNIE ENMD Stock Options (Right to Buy) A - Award D 2,30 50.000 50.000
2012-03-14 2012-03-12 4 RANDALL MARK C M ENMD Stock Options (Right to Buy) A - Award D 2,30 50.000 50.000
2012-03-02 2012-03-01 4 He Wei-Wu ENMD Stock Options (Right to Buy) A - Award D 1,95 250.000 250.000
2012-02-13 3 Mak Tak W. ENMD Common Stock D 12.519
2012-02-13 3 He Wei-Wu ENMD Common Stock D 24.698
2012-01-25 2012-01-23 4 Hu Cynthia W. ENMD Stock Options (Right to Buy) A - Award D 1,75 100.000 100.000
2012-01-25 2012-01-23 4 BROOKS DONALD S ENMD Stock Options (Right to Buy) A - Award D 1,75 25.000 25.000
2012-01-25 2012-01-23 4 TARNOW MICHAEL M ENMD Stock Options (Right to Buy) A - Award D 1,75 50.000 50.000
2012-01-25 2012-01-23 4 BUSH DWIGHT L ENMD Stock Options (Right to Buy) A - Award D 1,75 50.000 50.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista